Tumgik
#traveller’sdiarrhoeatreatmentmarket
Text
Global Traveller’s Diarrhoea Treatment Market Size to Grow at a CAGR of 6.0% in the Forecast Period of 2022-2027
The ‘Global Traveller’s Diarrhoea Treatment Market Size, Share, Research, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of the global traveller’s diarrhoea treatment market, assessing the market on the basis of its segments like drug types, pathogens, ages, distribution channels, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/travellers-diarrhoea-treatment-market/requestsample
Traveller’s Diarrhoea Treatment Market Share, Size, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2017-2027)
Forecast CAGR (2022-2027): 6.0%
According to the National Library of Medicine, a significant section of travellers across the world suffer from traveller’s diarrhoea. The surge in the prevalence of the disorder can be attributed to the increased exposure to bacteria and viruses, especially in developing countries. Therefore, the growing health awareness and increasing focus on personal wellbeing during travelling are driving the traveller’s diarrhoea treatment market.
The rising rates of hospitalisation of traveller’s diarrhoea owing to the requirement of optimal oral rehydration solutions and clean and hygienic nourishment are accelerating the demand for traveller’s diarrhoea treatment. In addition, this surge in hospitalisation rate is likely to bolster the demand for antidiarrhoeal medication, including azithromycin, ciprofloxacin, and rifaximin, among others.
Over the forecast period, the anticipated rise in awareness about the traveller’s diarrhoea prevention medication, such as loperamide, is expected to support the growth of traveller’s diarrhoea treatment market. Besides, the growing popularity of travelling as a recreational activity among the working-class population is likely to expand the demand for traveller’s diarrhoea medications. The market is also anticipated to be aided by the easy utilisation of standby antibiotic medicines for the recovery from traveller’s diarrhoea by travellers visiting less-travelled or exotic locations.
In terms of region, the Asia Pacific accounts for a significant share of the market due to the increasing prevalence of traveller’s diarrhoea in Southeast Asia. The surge in the number of tourists and domestic travellers across emerging economies, including India, China, Indonesia, Malaysia, and Singapore, among others, are anticipated to escalate the cases of traveller’s diarrhoea in the forecast period.
Meanwhile, the North America traveller’s diarrhoea treatment market is likely to witness a steady growth in the coming years owing to the strong foothold of major market players in countries such as the United States and Canada.
Traveller’s Diarrhoea Treatment Industry Definition and Major Segments
Traveller’s diarrhoea is a type of disorder which attacks the health of the digestive tract, leading to the excretion of watery stools. It also causes cramps in the abdominal area of the body. Consumption of unhealthy junk food and beverage is the main cause of this disorder. Traveller’s diarrhoea treatment aims at bolstering the health of the patients suffering from this disease using various medications.
Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/travellers-diarrhoea-treatment-market
Based on drug type, the market can be segmented into:
Oral Rehydration Therapy (ORS)
Antidiarrhoeal Agents
Vaccines/Prophylactics
Others
Antibiotics
Azithromycin
Ciprofloxacin
Quinolones
Rifaximin
Others
The market can be broadly categorised based on pathogen into:
Bacteria
Viruses
Protozoa
Others
By age, the traveller’s diarrhoea treatment market segmented into:
Adult
Children
On the basis of distribution channel, the market is segmented into:
Hospital Pharmacies
Drug Store
Online
On the basis of region, the market can be categorised into:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Traveller’s Diarrhoea Treatment Market Trends
The key trends in the global traveller’s diarrhoea treatment market growth include the thriving travel and tourism industry and the increasing inclination towards travelling to developing countries for rich cultural experiences. Therefore, the rising number of travellers is likely to increase their exposure to viruses and bacteria, which are the major causes of traveller’s diarrhoea.
The growing research and development activities by various pharmaceutical and biopharmaceutical companies aimed towards developing efficient antibiotic resistance are likely to support the market. Furthermore, the development of edible vaccines for the early prevention of traveller’s diarrhoea is expected to provide lucrative growth opportunities to the traveller’s diarrhoea treatment market.
The robust development of healthcare infrastructure, the expansion of healthcare units, and the rising per capita income in the emerging economies are likely to significantly contribute to the market for traveller’s diarrhoea in the coming years.
The increasing geriatric population, coupled with the favourable reimbursement policies of the government, are anticipated to spearhead the market growth in the forecast period. Furthermore, the rapid expansion of online medical stores, coupled with the flourishing e-commerce sector, is likely to propel the sale of traveller’s diarrhoea treatment antibiotics and edibles.
Key Market Players
The major players in the traveller’s diarrhoea treatment market research report are:
Bausch Health Companies Inc.
COSMO Pharmaceuticals
Immuron Ltd.
Sanofi SA
Others
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact:
Company Name: Claight Corporation Contact Person: Steven Luke, Business Consultant Email: [email protected] Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790 Address: 30 North Gould Street, Sheridan, WY 82801, USA Website: https://www.expertmarketresearch.com LinkedIn:- https://www.linkedin.com/company/expert-market-research
3 notes · View notes